Government Price Setting Threatens The Many Significant Innovations Generated After Initial FDA Approval

Teaser image for PhRMA's fact sheet on risks to the post-approval process for Cancer treatments

Innovation doesn’t stop when the U.S. Food and Drug Administration (FDA) approves a new prescription medicine. Biopharmaceutical companies continue to research treatments after FDA approval to see if they can be used in new ways to improve patient care, especially in disease areas like cancer.

Teaser image for PhRMA's fact sheet on risks to the post-approval process for Cancer treatments